(Q46160863)

20 December 2017

title

Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results (English)

1 reference

20 December 2017

1 reference

chronic heart failure

1 reference

10

1 reference

20 December 2017

Giovanni de Simone

13

1 reference

20 December 2017

author name string

Alessandro Boccanelli

1

1 reference

20 December 2017

Gian Francesco Mureddu

2

1 reference

20 December 2017

Giuseppe Cacciatore

3

1 reference

20 December 2017

Francesco Clemenza

4

1 reference

20 December 2017

Andrea Di Lenarda

5

1 reference

20 December 2017

Antonello Gavazzi

6

1 reference

20 December 2017

Maurizio Porcu

7

1 reference

20 December 2017

Roberto Latini

8

1 reference

20 December 2017

Donata Lucci

9

1 reference

20 December 2017

Serge Masson

11

1 reference

20 December 2017

Massimo Vanasia

12

1 reference

20 December 2017

AREA IN-CHF Investigators

14

1 reference

20 December 2017

publication date

1 January 2009

1 reference

20 December 2017

European Journal of Heart Failure

published in

1 reference

20 December 2017

volume

11

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

68-76

1 reference

20 December 2017

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Pathophysiologic and therapeutic importance of tissue ACE: a consensus report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Aldosterone escape during ACE inhibitor therapy in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

"Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Guidelines for the diagnosis and treatment of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Serial echocardiographic assessment of left ventricular mass: how blinded should readers be?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Perceived benefit after participating in positive or negative/neutral heart failure trials: the patients' perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

The interplay between haemodynamic load, brain natriuretic peptide and left atrial size in the early stages of essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Left atrial size: physiologic determinants and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Development and validation of an HPLC method for the determination of spironolactone and its metabolites in paediatric plasma samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Added benefit of mineralocorticoid receptor blockade in the primary prevention of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Baseline characteristics of patients recruited in the AREA IN-CHF study (Antiremodelling Effect of Aldosterone Receptors Blockade with Canrenone in Mild Chronic Heart Failure)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: The ACTION study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN015

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFN015

1 reference

20 December 2017

release_i7xtz6m2nbe3ln2y4tlc3pdyfa

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i7xtz6m2nbe3ln2y4tlc3pdyfa

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

19147459

1 reference

20 December 2017